Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2004 Aug;42(8):3857-60.
doi: 10.1128/JCM.42.8.3857-3860.2004.

V-antigen genotype and phenotype analyses of clinical isolates of Pseudomonas aeruginosa

Affiliations
Comparative Study

V-antigen genotype and phenotype analyses of clinical isolates of Pseudomonas aeruginosa

Leonard R Allmond et al. J Clin Microbiol. 2004 Aug.

Abstract

The pcrV genotype was analyzed in clinical isolates of Pseudomonas aeruginosa which showed a negative phenotype for secretion of V-antigen PcrV. The suppression of PcrV secretion in these isolates was due not to a lack of the pcrV gene but rather to suppression of PcrV expression.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Detection of pcrV in clinical isolates of P. aeruginosa by PCR. pcrV genes were amplified by PCR using genomic DNA from clinical isolates of P. aeruginosa as template DNA and a specific primer set outside of the coding region (Table 2). The PCR products were analyzed by 0.9% agarose gel electrophoresis and ethidium bromide staining. PCR genotyping analysis showed that all isolates possessed pcrV. The figure shows data for 20 clinical isolates and a laboratory strain, PA103.
FIG. 2.
FIG. 2.
Phenotype analysis of PcrV expression and secretion in clinical isolates of P. aeruginosa. Immunoblot analysis by a highly sensitive chemiluminescence method was used to determine the phenotype of PcrV secretion in selected P. aeruginosa isolates. PcrV proteins from P. aeruginosa PA103 (a laboratory strain) and PA1027 (a clinical isolate from an acutely infected patient) were used as positive controls for detection. Isolates were cultured in Luria-Bertani medium overnight, and the next day, 10% of the volume of the overnight culture was transferred into Ca2+-chelating deferrated tryptic soy broth medium and cultured for 8 h at 32°C. (Top panels) PcrV secreted into the inducing culture medium. (Bottom panels) PcrV in cell-associated fractions. PcrV was recognized as a 34-kDa band.
FIG. 3.
FIG. 3.
In vivo PcrV expression in clinical isolates of P. aeruginosa. Immunoblot analysis by a chemiluminescence method was used to determine the expression of PcrV in P. aeruginosa isolates instilled in mice. Bacteria were recovered by BAL 4 h after instillation into the lungs. The bacterial density among the samples was adjusted by quantitative culture of BAL fluid on agar plates. The secreted protein from P. aeruginosa PA103 (a laboratory strain) was used as a positive control for PcrV detection. PcrV was recognized as a 34-kDa band. PA1065 and PA1079 were isolates from cystic fibrosis patients and did not express PcrV in vivo.

References

    1. Bacon, G. A., and T. W. Burrows. 1956. The basis of virulence in Pasteurella pestis: an antigen determining virulence. Br. J. Exp. Pathol. 37:481-493. - PMC - PubMed
    1. Burrows, T. W., and G. A. Bacon. 1958. The effects of loss of different virulence determinants on the virulence and immunogenicity of strains of Pasteurella pestis. Br. J. Exp. Pathol. 39:278-291. - PMC - PubMed
    1. Dacheux, D., I. Attree, and B. Toussaint. 2001. Expression of ExsA in trans confers type III secretion system-dependent cytotoxicity on noncytotoxic Pseudomonas aeruginosa cystic fibrosis isolates. Infect. Immun. 69:538-542. - PMC - PubMed
    1. Dacheux, D., O. Epaulard, A. de Groot, B. Guery, R. Leberre, I. Attree, B. Polack, and B. Toussaint. 2002. Activation of the Pseudomonas aeruginosa type III secretion system requires an intact pyruvate dehydrogenase aceAB operon. Infect. Immun. 70:3973-3977. - PMC - PubMed
    1. Ernst, E. J., S. Hashimoto, J. Guglielmo, T. Sawa, J. F. Pittet, H. Kropp, J. J. Jackson, and J. P. Wiener-Kronish. 1999. Effects of antibiotic therapy on Pseudomonas aeruginosa-induced lung injury in a rat model. Antimicrob. Agents Chemother. 43:2389-2394. - PMC - PubMed

Publication types

LinkOut - more resources